Daniel J. Hicklin

City:

Montclair, New Jersey

Country:

United States

Published Applications:

Last publication date:

2025-07-03

Top Assignees for applications by Daniel J. Hicklin

The entities that hold a legal rights for patent applications filed by inventor Hicklin Daniel J.:

NOVARTIS AG 5 Basel, Switzerland
Dana-Farber-Cancer Institute, Inc. 4 Boston, MA United States
Children"s Medical Center Corporation 3 Boston, MA United States
The Children's Medical Center Corporation 2 Boston, MA United States
IMCLONE LLC 1 New York, NY United States
DANA-FARBER CANCER INSITITUTE, INC. 1 Boston, MA United States

Recent patent applications by Hicklin Daniel J.

Daniel J. Hicklin from Montclair, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-03

US20250213684A1

Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#2 | 2022-06-16

US20220185883A1

Chemistry; metallurgy

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

#3 | 2022-05-05

US20220133889A1

Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#4 | 2020-10-01

US20200308277A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#5 | 2020-07-16

US20200223917A1

Chemistry; metallurgy

Method of detecting TIM-3 using antibody molecules to TIM-3

#6 | 2018-07-26

US20180207273A1

Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#7 | 2017-07-13

US20170198041A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#8 | 2017-07-06

US20170190777A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#9 | 2015-08-06

US20150218274A1

Chemistry; metallurgy

Antibody molecules to TIM-3 and uses thereof

#10 | 2010-02-04

US20100028347A1

Chemistry; metallurgy

Antibodies against vascular endothelial growth factor receptor-1

InventorID:

1247327 ⎘